Pharmafile.com’s weekly COVID-19 news round-up
May 13, 2020Research and Development COVID-19, coronavirus
Developments in treatments for COVID-19 continue to dominate the news as the latest in hydroxychloroquine trials shows it does not …
Researchers in Denmark testing if senicapoc drug can reduce lung damage in COVID-19 patients
May 13, 2020Research and Development COVID-19, Sars, coronavirus
Scientists are studying if senicapoc, a treatment for sickle cell anemia, can be repurposed to mitigate damage to a COVID-19 …
Japan authorises exceptional approval of Gilead’s remdesivir for severe COVID-19
May 12, 2020Manufacturing and Production, Sales and Marketing COVID-19, Gilead, Japan, coronavirus, pharma, remdesivir
Remdesivir, perhaps the leading hope in the race against COVID-19, has secured approval from Japan’s Ministry of Health, Labour and …
FDA grants Abbott Emergency Use Authorization for another COVID-19 antibody test
May 12, 2020Manufacturing and Production COVID, COVID-19, coronavirus, pandemic, tests
The FDA has given Emergency Use Authorisation for another COVID-19 diagnostics test for antibodies from Abbott Laboratories. With this approval, …
Wuhan plans to test all 11 million residents for COVID-19 after 6 new cases are recorded
May 12, 2020Manufacturing and Production COVID-19, coronavirus, pandemic
The Chinese city of Wuhan, where the coronavirus originated, plans to test all of its residents after 6 new cases …
Genfit’s NASH drug fails Phase 3 clinical trial
May 12, 2020Manufacturing and Production FDA, nash
The Phase 3 trial for Genfit’s drug elafibranor has failed to improve outcomes for patients with the fatty liver disease …
FDA provides new guidelines to accelerate the development of COVID-19 treatments
May 12, 2020Manufacturing and Production COVID-19, FDA, coronavirus, pandemic
The FDA has provided new guidelines to researchers studying potential COVID-19 treatments to help speed up the process of their …
What can previous outbreak modeling tell us about the COVID-19 pandemic?
May 11, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Interview, coronavirus, feature, pharma
Dr LaRee Tracy, a lecturer at San Diego State University and Director of Biostatistics at PHASTAR, led a team of …
Takeda’s subcutaneous Entyvio approved in Europe for maintenance of moderate to severe Crohn’s and ulcerative colitis
May 11, 2020Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, ulcerative colitis
The European Commission has awarded marketing approval to Takeda’s subcutaneous formulation of its gut-selective biologic therapy Entyvio (vedolizumab) as a …
Latest large hydroxychloroquine study suggests it does not help treat COVID-19
May 11, 2020Sales and Marketing COVID-91, coronavirus, hydroxychloroquine
The results of another study into the use of hydroxychloroquine in COVID-19 patients has cast further doubts on its effectiveness …
Lynparza combo authorised in US for first-line maintenance of HRD-positive advanced ovarian cancer
May 11, 2020Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer
Lynparza (olaparib), developed by AstraZeneca and MSD, has secured FDA approval when paired with bevacizumab as a first-line maintenance treatment …
Eli Lilly’s Retevmo approved by FDA to treat lung and thyroid cancers
May 11, 2020Sales and Marketing COVID-19, coronavirus
The FDA has announced that Retevmo (selpercatinib) has been approved to treat both non-small-cell lung cancer (NSCLC) and medullary thyroid …
NIAID announces the launch of second remdesivir trial for COVID-19 patients
May 11, 2020Sales and Marketing COVID-19, coronavirus, niaid, remdesivier
The US National Institute of Allergy and Infectious Diseases (NAID) has announced that it is enrolling COVID-19 patients in hospital …
NICE gives thumbs-up to Roche’s Kadcyla in HER2+ breast cancer sub-population
May 7, 2020Sales and Marketing Cancer, Kadcyla, NHS, NICE, Roche, UK, breast cancer
NICE has revealed that it has recommended the NHS use of Roche’s Kadcyla (trastuzumab emtansine) for HER2+ breast cancer in …
Black people are four times more likely to die from COVID-19 than white in England and Wales, ONS report shows
May 7, 2020Business Services COVID-19, coronavirus
A recent report from the Office of National Statistics has shown that black people in England and Wales are four …
FDA approval for Tabrecta in metastatic non-small cell lung cancer with METex14
May 7, 2020Sales and Marketing Incyte, Novartis, Tabrecta, pharma
The FDA has awarded marketing authorisation to Novartis for the Oral MET inhibitor Tabrecta (capmatinib) for the first-line treatment of metastatic non-small …
UK becomes first European country to pass 30,000 deaths from COVID-19
May 7, 2020Business Services COVID-19, coronavirus
Britain has become the first European nation to pass 30,000 deaths from the coronavirus, putting it only behind the US as …
Scientists in the UK and US identify hundreds of mutations in the COVID-19 virus
May 7, 2020Business Services COVID-19, Protein, coronavirus, virus
Two studies from the UK and US have identified hundreds of mutations in COVID-19, which could cause problems for the …
South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients
May 6, 2020Research and Development COVID-19, coronavirus, south korea
South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. South …
AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction
May 6, 2020Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure
The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
